POTENTIAL COVID-19 DRUG EFFECTIVE IN LAB Peptide reduced COVID-19 symptoms in mice A new therapy developed by researchers at Rush University Medical Center shows success as a way to prevent COVID-19 symptoms in mice. In a study published in the Journal of Neuroimmune Pharmacology, mouse models with COVID-19 showed positive results when a small peptide was introduced nasally. The peptide proved effective in reducing fever, protecting the lungs, improving heart function, and reversing cytokine storm -- a condition in which an infection triggers the immune system to flood the bloodstream with inflammatory proteins. The researchers also report success in preventing the disease from progression. "This could be a new approach to prevent SARS-CoV-2 infection and protect COVID-19 patients from breathing problems and cardiac issues," said Kalipada Pahan, Ph.D., the Floyd A. Davis Professor of Neurology at Rush and a Research Career Scientist at the Jesse Brown VA Medical Center. &
Protimefit shares information on the latest research regarding health and wellness for better living. Our goal is to equip individuals with information that may help in making good decisions that ensure the highest quality of life. Protimefit also offers health consulting and coaching for those who require help with specific concerns such as weight loss, and other lifestyle modifications. Life coaching services are also available.